Cupid Ltd has increased its investment in GII’s healthcare-focused investment platform with an additional $5 million follow-on investment, according to a regulatory filing with the BSE. The investment has been funded entirely through internal accruals.
The company said that the investment was made at an attractive valuation, allowing it to further strengthen its participation in the platform’s future growth. However, it did not disclose the size of its stake following the latest investment.
According to the filing, GII is a leading investment firm with AUM exceeding $3.5 billion and a global presence across Saudi Arabia, the UAE, Europe, the USA, and India.
The company’s statement revealed that GII Healthcare Investment currently holds a significant equity stake in a prominent healthcare provider based in Saudi Arabia, and has invested in high-quality healthcare assets globally, including Abeer Medical Company, one of Saudi Arabia's leading integrated healthcare providers, and AlMeswak Dental Company.
ccording to Cupid’s statement, the Gulf Cooperation Council healthcare sector continues to present compelling long-term growth opportunities, supported by increasing healthcare expenditure, expanding populations, rising insurance penetration, and sustained government investment across the region.
Cupid Ltd is a manufacturer of health and personal care products, including wellness and hygiene products for men and women, diagnostic kits, fragrances, and other FMCG products.
Commenting on Cupi’s global expansion, Chairman & MD Aditya Kumar Halwasiya said that this follow-on investment reiterates their confidence in both the quality of the underlying healthcare assets and the long-term value creation potential of the platform.
Cupid Share Price
Shares of Cupid have gained over 20% in July, following a 6-day rally in early July. The stock has gained nearly 131% over the last three months.
Cupid’s Q1 Business Update
Cupid at the end of June said it is on track to report revenue exceeding Rs 150 crore in the first quarter of FY27, which it described as one of the strongest quarterly performances in its history. Aided by the strong start to the financial year and improved visibility across international and domestic markets, the company has also raised its FY27 revenue guidance.
